Invention Grant
- Patent Title: Chimeric RSV, immunogenic compositions, and methods of use
-
Application No.: US15772275Application Date: 2016-10-27
-
Publication No.: US11235050B2Publication Date: 2022-02-01
- Inventor: Martin L. Moore , Christina Rostad
- Applicant: EMORY UNIVERSITY
- Applicant Address: US GA Atlanta
- Assignee: EMORY UNIVERSITY
- Current Assignee: EMORY UNIVERSITY
- Current Assignee Address: US GA Atlanta
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2016/058976 WO 20161027
- International Announcement: WO2017/075125 WO 20170504
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K14/005 ; C12N7/00 ; A61K39/00 ; A61P11/00
Abstract:
This disclosure relates to chimeric respiratory syncytial virus (RSV), live attenuated vaccine and immunogenic compositions, and methods of use. In certain embodiments, the chimeric respiratory syncytial virus has a mutated gene pattern encoding an RSV F protein having M at position 79, R at position 191, K at position 357, and/or Y at position 371.
Public/Granted literature
- US20180333477A1 CHIMERIC RSV, IMMUNOGENIC COMPOSITIONS, AND METHODS OF USE Public/Granted day:2018-11-22
Information query
